Preload Optimization Guided by Inferior Vena Cava Collapsibility Index
NCT04272580
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
193
Enrollment
OTHER
Sponsor class
Conditions
Adverse Effect
Interventions
DRUG:
Control group
DRUG:
4 ml/kg group.
DRUG:
8 ml/kg group.
DRUG:
12 ml/kg group.
Sponsor
General Hospital of Ningxia Medical University